Worldwide Clinical Trials Brochures

  1. Cardiovascular Clinical Development 10/16/2024

    Worldwide offers a full suite of services and a team of experts to support your cardiovascular therapy development and ensure your program's success throughout all clinical phases.

  2. Game Changers In Clinical Trials: The Power Of Top- Performing Project Managers 9/16/2024

    Uncover what information we discovered in our CRO survey, and how we're utilizing this information to enhance our services and build stronger, more successful partnerships with our clients.

  3. Addressing Top Concerns And Unmet Needs In Oncology Research 8/29/2024

    Discover how over 140 global clinical outsourcing decision-makers view their key challenges and see why many oncology trial sponsors are turning to flexible, personalized solutions for greater stability.

  4. CGT Development At Worldwide Clinical Trials 8/27/2024

    Our therapeutically aligned clinical operations team delivers comprehensive, full-service solutions across a diverse array of therapeutic areas and treatment modalities.

  5. Site Alliances: The Power Of Site Engagement 11/10/2022

    Here at Worldwide Clinical Trials, we created the Site Alliance Collaboration, not just targeting major academic centers, but all types of sites in order to deliver the most efficient trials for our clients.

  6. Make Informed Decisions, Faster 10/5/2022

    For more than 15 years, Worldwide Clinical Trials has been a trusted market leader in bioanalysis. Our scientific heritage not only means we have accessible expertise to work closely with you, but also means we are compulsive about quality.

  7. Adaptive Trial Design — Is It Right For Your Clinical Study? 9/7/2022

    Worldwide Clinical Trials’ extensive adaptive trial knowledge (from protocol design through data collection and analysis) can help you fully realize the potential benefits of adaptive trial design methodology.

  8. Keeping NDA On Schedule After Unexpected FDA Feedback 4/4/2022

    Gain insight into how five last-minute studies were accommodated, executed, analyzed, and properly documented for the FDA and EMA in just 8 months.